Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/23/2025
China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...
12/23/2025
PepBio Raises Series A Financing to Advance AI-Driven Peptide Drug Pip...
12/23/2025
T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf CAR-T Therapy
12/23/2025
Ipsen Expands Oncology Pipeline with Global Licensing of Simcere Zaimi...
12/23/2025
Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Triple Antibody QLS2...
12/23/2025
Grand Secures China Rights to World's First Adrenaline Nasal Spray fr...
12/23/2025
CSPC Announces China Approval for Daratumumab Injection
12/23/2025
Aurobindo Pharma to Increase Stake in Chinese JV Luoxin Aurovitas
12/23/2025
NSCEB: US Faces Urgent Challenge to Stay Ahead of China in Biotech
12/22/2025
China Biopharma Licensing Slows in Value as Overseas Outbound Deals Re...
12/22/2025
Epigenic Wins FDA IND Clearance for Novel Epigenetic Therapy Targeting...
12/22/2025
Rezubio Raises $20M Series A to Advance Membrane-Anchored Therapeutics...
12/22/2025
Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 Accepted in Chi...
12/22/2025
AstraZeneca Strengthens KRAS Oncology Strategy with Pan-KRAS Deal from...
12/22/2025
Zelgen Files for Hong Kong IPO, Showcasing Commercial Portfolio and Mu...
12/22/2025
Windward Bio Licenses Long-Acting TSLP/IL-13 Bispecific WIN027 from Qy...
12/22/2025
NMPA Announces Revision of Montelukast Product Labels to Strengthen Dr...
12/19/2025
Fosun Partners with ClavisBio in Global Oncology Collaboration with Op...
12/19/2025
Insilico Targets US$292 Million in Hong Kong IPO to Advance AI-Driven ...
12/19/2025
China Seeks Public Comments on Draft 101st Batch of Reference Formulat...
12/19/2025
Recent Executive Moves
12/19/2025
U.S. Biosecurity Provisions Could Reshape China's Role in Global Biote...
12/18/2025
Valink and Nona Form Strategic Alliance to Accelerate Novel Biologics...
12/18/2025
Byrtna Secures Angel+ Financing to Advance Circular mRNA In Vivo CAR-T...
12/18/2025
Phil Rivers Raises CNY 100M in Series A1 to Advance Digital Twin–Dr...
12/18/2025
Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...
12/18/2025
Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...
12/18/2025
CSL Elevates China to Core Global Strategic Market
12/18/2025
China Grants First Global Approval to Cytokinetics' Cardiomyopathy Dru...
12/18/2025
HUTCHMED Initiates Global Clinical Development of FIC ATTC Candidate H...
Page:
1
/
807
Total number of articles:
24185
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit